(IN BRIEF) According to an independent report, the cost of prescription medicines to the NHS in England reached a record high of £17.2 billion in the financial year 2021-2022. The report reveals that NHS spending on branded medicines has been … Read the full press release
Posted in Education, Government, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Beth Woods, cancer drugs, cost of prescription medicines, COVID-19 vaccines, Dr Huseyin Naci, Dr James Lomas, e Voluntary Scheme for Branded Medicines Pricing and Access, immunosuppression, London School of Economics and Political Science, London School of Hygiene & Tropical Medicine, LSE, LSHTM, malignant disease, medicines, NHS, REPORT, respiratory system disorders, University of York, VPAS
(IN BRIEF) The European Investment Bank (EIB) is investing €40 million in Wingcopter, a European drone delivery technology company. Wingcopter’s electrically powered unmanned aircraft have already been successfully used in small-scale commercial and humanitarian projects, including delivering medical supplies in … Read the full press release
Posted in Aviation & Aerospace, Banks, Business, European Union, Financial, Germany, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Transportation & Logistics
Tagged BM, Drones, EIB, electric cargo drones, European Investment Bank, Expa, Garrett Camp, Gesellschaft für Internationale Zusammenarbeit, GIZ, InvestEU, Itochu, logistics, medical supplies, medicines, Paolo Gentiloni, REWE Group, Tom Plümmer, UNICEF, unmanned delivery drone, Wingcopter GmbH, Xplorer Capital
(IN BRIEF) Boehringer Ingelheim has begun construction on a new Chemical Innovation Plant at its headquarters in Ingelheim, Germany. The €285 million investment will develop manufacturing processes for active pharmaceutical ingredients and produce drugs for clinical trial phases, enabling Boehringer … Read the full press release
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release
Posted in Artificial Intelligence (AI), Healthcare, Management, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Academy of Medical Sciences, Adrestia, Altius Institute, Altos Labs, appointment, artificial-intelligence, biotechnology, Blenrep, Board of the Rosalind Franklin Institute, Cabenuva, Chief Scientific Officer, CSO, Dr. Hal Barron, Emma Walmsley, Genome Research, genomics, GlaxoSmithKline plc, GSK, immunology, Imperial College, infectious disease, Jemperli, Machine Learning, medicines, Nucala®, oncology, Pfizer, R&D, research and development, Royal Society of Biology, Royal Society of Chemistry, Tony Wood, UK National Genomics Board, University of Newcastle, Xevudy
Agreement sharpens AstraZeneca’s focus on priority medicines in Respiratory & Immunology portfolio (PRESS RELEASE) CAMBRIDGE, 1-Nov-2021 — /EuropaWire/ — AstraZeneca (LON: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced it sold the global rights of its chronic obstructive … Read the full press release
Posted in Business, Healthcare, Management, News, Pharma & Biotech
Tagged Aclidinium bromide, Almirall S.A., Alvesco, AstraZeneca, biopharmaceutical, Bretaris, Chronic obstructive pulmonary disease, COPD, Covis Pharma, Covis Pharma Group, Duaklir, Eklira, formoterol, Genuair, Genuair device, global rights, inhaler, LABA, LAMA, long-acting beta2-agonist, long-acting muscarinic antagonist, medicines, Omnaris, Pressair, respiratory medicines, rights, Tudorza, Zetonna
(PRESS RELEASE) ESPOO, 26-Oct-2021 — /EuropaWire/ — Gasum, a Finnish state-owned energy company responsible for the import of the nation’s natural gas, has announced that its biogas is used in the Post Nord’s biogas-powered vehicles for the transportation of medicines … Read the full press release
Posted in Environment, Finland, Industrial, Infrastructure & Utilities, News, Pharma & Biotech, Transportation & Logistics
Tagged biogas, biogas-powered vehicles, climate friendly, climate goals, Gasum biogas, health products, Ilmo Strömberg, Katja Toivonen, logistics, Markku Suopanki, medicines, NOx, pharmaceuticals, Post Nord, PostNord, SoX, Tamro
(PRESS RELEASE) GENEVA, 26-Mar-2020 — /EuropaWire/ — Inspection, verification, testing and certification company SGS announced it has developed a test method to identify nitrosamine impurities in drug products, raw materials and APIs. In 2018, the presence of the nitrosamine N-nitrosodimethylamine … Read the full press release
(PRESS RELEASE) LEVERKUSEN, 28-Jan-2020 — /EuropaWire/ — Bayer is supporting people affected by the novel coronavirus outbreak in China. The pharmaceutical company is contributing medicines and financial help worth of approximately EUR 1.5 million. The donations will be sent to … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Society
Tagged Avelox®, Bayer, CHINA, Chinese Red Cross, coronavirus, donatiion, financial aid, Gadovist, medicines, Redoxon®, Saridon®, Ultravist®, Werner Baumann, Wuhan
(PRESS RELEASE) BERLIN, 14-Aug-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) today announced representatives of seven health authorities have been invited to speak at the 2019 PDA Europe Biomanufacturing Conference, 3-4 September 2019 in Munich, Germany. The following health … Read the full press release
Posted in Denmark, France, Germany, Healthcare, Italy, Media, Netherlands, News, Pharma & Biotech, Science, Spain, Sweden, United Kingdom
Tagged Accelerated Access, biopharmaceuticals, Continuous Manufacturing, Danish Medicines Agency, Dolores Hernan, Dutch Medicines Evaluation Board, European Directorate for the Quality of Medicines & Healthcare (EDQM), European Medicines Agency, GMP, Gwenael Cirefice, Manufacturing, Martjin van der Plas, Mats Welin, medicines, Nanna Kruse, PDA, Regulation, Swedish Medicines Agency
EMA, MHRA and FDA among regulatory agencies participating (PRESS RELEASE) BERLIN, 10-Jun-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in … Read the full press release
Posted in France, Germany, Healthcare, Ireland, Media, Netherlands, News, Pharma & Biotech, Science, Switzerland, United Kingdom
Tagged 4th PDA European Annual Meeting, Amsterdam, automation, Basel, Berlin, biopharmaceuticals, data quality management, data science, digitalization, Dublin, EMA, European Medicines Agency, FDA, Felix G. Rebitschek, Healthcare, HPRA, London, Manufacturing, manufacturing technologies, Max Planck Institute, medicines, MHRA, Paris, PDA, pharmaceuticals, PIC/S, regulators, Virtual Reality, Walter Morris, WHO, Zurich
Fresh design and improved features to provide better user experience LONDON, 25-Sep-2018 — /EuropaWire/ — The European Medicines Agency (EMA) will launch a new version of its corporate website (www.ema.europa.eu) on 27 September 2018. The new website will have an improved … Read the full press release
Posted in Internet & Online, Pharma & Biotech, United Kingdom
Tagged EMA, European Medicines Agency, medicines, website
Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison BASEL, 19-Apr-2018 — /EuropaWire/ — Roche … Read the full press release
Posted in Healthcare, Netherlands, Pharma & Biotech, Switzerland
Tagged Breakthrough Therapy, haemophilia, Hemlibra, inhibitors, medicines, Roche, Sandra Horning MD
CAMBRIDGE, 07-Mar-2018 — /EuropaWire/ — Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has … Read the full press release
Posted in Denmark, Education, Healthcare, Pharma & Biotech, United Kingdom
Tagged DRUGS, medicines, pharma, Professor Axel Zeitler, solids, University of Cambridge, University of Copenhagen
LONDON, 22-Jan-2018 — /EuropaWire/ — Science Minister Sam Gyimah announces £70 million to create new manufacturing centres to help speed up the development of new medicines. Funding through Industrial Strategy Challenge Fund (ISCF) will support projects including new manufacturing centres to speed … Read the full press release
Posted in Financial, Government, Healthcare, Pharma & Biotech, United Kingdom
Tagged Brain, funding, Industrial Strategy Challenge Fund, Innovate UK, medicines, rehabilitation, RESEARCH, Sam Gyimah, Sir Mark Walport, stroke, treatments, VR
Lundbeck aims to further improve its ability to launch new medicines through a new commercial structure. The initiative could lead to a reduction of around 50-55 positions in Europe. Valby, 21-6-2013 — /europawire.eu/ — H. Lundbeck A/S (Lundbeck) plans to further … Read the full press release
Posted in Business, Denmark, Healthcare, Management, Pharma & Biotech
Tagged Lundbeck, medicines, Ole Chrintz, restructure, restructuring plans, Valby
Brussels, 20-6-2013 — /europawire.eu/ — The European Commission has imposed a fine of € 93,8 million on Danish pharmaceutical company Lundbeck and fines totalling € 52,2 million on several producers of generic medicines. In 2002, Lundbeck agreed with each of these … Read the full press release
Posted in Belgium, Business, Denmark, European Union, Financial, Government, Healthcare, Law, Pharma & Biotech, Society
Tagged anticompetitive agreements, antidepressant medicine, ANTITRUST, blockbuster antidepressant, citalopram, citalopram molecule, EU antitrust rules, fine, generic medicines, Generics UK, Joaquin Almunia, lump sums, Lundbeck, medicines, Merck KGaA, Patents, pharmaceutical company, Ranbaxy, Zoetis
New process reduces energy consumption by roughly one-third / Trial phase completed successfully Leverkusen, 18-6-2013 — /europawire.eu/ — A new technology from Bayer and ThyssenKrupp that is now being launched commercially worldwide enables the production of chlorine with significantly less electricity. … Read the full press release
Posted in Business, Chemicals, Germany, Industrial, Science, Technology
Tagged Bayer, Bayer MaterialScience, chemical, Chlorine, chlorine producers, Chlorine production, crop protection agents, Dr. Tony Van Osselaer, electricity, electrolysis of table salt, energy consumption, Krefeld-Uerdingen, Leverkusen, medicines, oxygen depolarized cathode, plastics, ThyssenKrupp, ThyssenKrupp Uhde, UHDENORA
23-4-2013 — /europawire.eu/ — These sorts of new techniques potentially offer exciting possibilities to patients for the treatment of a range of difficult or previously untreatable conditions. Like all treatments, these techniques also come with benefits and risks. Specific rules were introduced … Read the full press release
Posted in European Union, Government, Healthcare, Law, Pharma & Biotech, Society, United Kingdom
Tagged EMA, European Medicines Agency, medicines, patients, Stem cell, Stem cell therapy, Stem cell therapy treatments, therapy, traceability of materials, treatment, treatment protocols, untreatable conditions
Key deliverable of Falsified Medicines Directive achieved 22-4-2013 — /europawire.eu/ — The European Medicines Agency has upgraded its EudraGMP database so that it now contains information on good distribution practice (GDP) in addition to good manufacturing practice (GMP). The new database, now called EudraGMDP, is a … Read the full press release
Posted in European Union, Government, Healthcare, Internet & Online, Pharma & Biotech, Technology
Tagged active substances, distributors, EudraGMDP, EudraGMP, European Falsified Medicines Directive, Falsified Medicines Directive, GDP, GDP certificates, GMP, good distribution practice, good manufacturing practice, importers, manufacturers, medicines, medicines regulatory authorities, statements of non-compliance with GDP, suppliers, The European Medicines Agency
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
